The World Health Organization has approved the emergency use of the LC16m8 vaccine against monkeypox, providing a new option for protection.

<p>The WHO has granted emergency authorization for the LC16m8 monkeypox vaccine, facilitating rapid access to treatment for affected communities. The decision comes against the backdrop of a new international emergency triggered by a surge in smallpox cases in Africa, largely driven by the new lb strain, which is increasingly prevalent in the Democratic Republic of Congo. Japan plans to provide 3.05 million doses of vaccine to support the DRC.